PuSH - Publikationsserver des Helmholtz Zentrums München

Isernhagen, A. ; Malzahn, D.* ; Monecke, S.* ; Schilling, D. ; Shah, P.* ; Multhoff, G. ; Wulf, G.* ; Kube, D.* ; Bickeböller, H.* ; Dressel, R.*

Functional consequences of genetic polymorphisms in the NKG2D receptor signaling pathway and putative gene interactions.

Recep. Clin. Invest., DOI: 10.14800/rci.1269 (2016)
Verlagsversion DOI
Open Access Gold
Creative Commons Lizenzvertrag
NKG2D (NK group 2, member D) is an activating natural killer (NK) receptor, which is expressed on NK and CD8+ T cells. On NK cells, NKG2D elicits cytotoxicity and release of cytokines. On CD8+ T cells, it functions as a co-stimulatory molecule. The receptor recognizes several ligands including the major histocompatibility complex (MHC) class I chain-related molecules A (MICA) and B (MICB) as well as the UL16-binding proteins (ULBP). The diversity of NKG2D ligands is further increased by a high degree of genetic variability of the ligands. Recently, an amino acid exchange from valine to methionine at position 129 in MICA has been found to be associated with the outcome of allogeneic hematopoietic stem cell transplantation (HSCT), and the functional consequences of this specific genetic variation have been elucidated. The clinical associations found after HSCT were explainable by the functional differences of the MICA-129 variants. Herein, we discuss how the genetic polymorphisms of NKG2D ligands and NKG2D itself interact and may affect the outcome of HSCT and the susceptibility to other diseases, which have been associated with polymorphisms in the NKG2D signaling pathway.
Altmetric
Weitere Metriken?
[➜Einloggen]
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Korrespondenzautor
ISSN (print) / ISBN 2330-0566
Zeitschrift Receptors & Clinical Investigation
Verlag Smart Science & Technology
Nichtpatentliteratur Publikationen
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Radiation Medicine (IRM)